Bacterial superantigens enhance the in vitro proinflammatory response and in vivo lethality of the TLR2 agonist bacterial lipoprotein

Journal of Immunology

Volumn 187, Issue 10, 2011, Pages 5363-5369

  Kearney, David E ^a   Wang, Wei ^a   Redmond, H Paul ^a   Wang, Jiang Huai ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPROTEIN; INTERLEUKIN 6; LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SUPERANTIGEN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LETHALITY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEPTIC SHOCK; TOXICITY TESTING;

ANIMALS; CELLS, CULTURED; CYTOKINES; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; STAPHYLOCOCCAL INFECTIONS; SUPERANTIGENS; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 81455154939     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003747     Document Type: Article

References (39)

1. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546-1554. (Pubitemid 36437931)
2. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150. (Pubitemid 36056721)
3. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891. (Pubitemid 36019643)
4. Proft, T., and J. D. Fraser. 2003. Bacterial superantigens. Clin. Exp. Immunol. 133: 299-306. (Pubitemid 37051503)
5. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248: 705-711.
6. Hopkins, P. A., J. D. Fraser, A. C. Pridmore, H. H. Russell, R. C. Read, and S. Sriskandan. 2005. Superantigen recognition by HLA class II on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin. Blood 105: 3655-3662. (Pubitemid 40628213)
7. Hopkins, P. A., A. C. Pridmore, S. Ellmerich, J. D. Fraser, H. H. Russell, R. C. Read, and S. Sriskandan. 2008. Increased surface toll-like receptor 2 expression in superantigen shock. Crit. Care Med. 36: 1267-1276. (Pubitemid 351482677)
8. Kreutz, M., U. Ackermann, S. Hauschildt, S. W. Krause, D. Riedel, W. Bessler, and R. Andreesen. 1997. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccous aureus in human monocytes. Immunology 92: 396-401. (Pubitemid 27488153)
9. Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736-739.
10. Zhang, H., D. W. Niesel, J. W. Peterson, and G. R. Klimpel. 1998. Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect. Immun. 66: 5196-5201. (Pubitemid 29044609)
11. Zhang, H., J. W. Peterson, D. W. Niesel, and G. R. Klimpel. 1997. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J. Immunol. 159: 4868-4878. (Pubitemid 127471023)
12. Kim, Y. B., and D. W. Watson. 1970. A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J. Exp. Med. 131: 611-622.
13. Kanof, M., P. Smith, and H. Zola. 2001. Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr. Protoc. Immunol. Chap. 7, Unit 7.1.
14. Wahl, L. M., S. M. Wahl, L. E. Smythies, and P. D. Smith. 2006. Isolation of human monocyte populations. Curr. Protoc. Immunol. 7: 7.6A.
15. Seager Danciger, J., M. Lutz, S. Hama, D. Cruz, A. Castrillo, J. Lazaro, R. Phillips, B. Premack, and J. Berliner. 2004. Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J. Immunol. Methods 288: 123-134. (Pubitemid 38739258)
16. Udono, H., D. L. Levey, and P. K. Srivastava. 1994. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc. Natl. Acad. Sci. USA 91: 3077-3081. (Pubitemid 24130178)
17. Goldmann, O., M. Rohde, G. S. Chhatwal, and E. Medina. 2004. Role of macrophages in host resistance to group A streptococci. Infect. Immun. 72: 2956-2963. (Pubitemid 38542426)
18. Raingeaud, J., S. Gupta, J. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270: 7420-7426.
19. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397. (Pubitemid 27334820)
20. Modlin, R. L., H. D. Brightbill, and P. J. Godowski. 1999. The toll of innate immunity on microbial pathogens. N. Engl. J. Med. 340: 1834-1835. (Pubitemid 29266411)
21. Leung, D. Y. 2000. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 105: 860-876. (Pubitemid 30324392)
22. Leung, D. Y., P. Walsh, R. Giorno, and D. A. Norris. 1993. A potential role for superantigens in the pathogenesis of psoriasis. J. Invest. Dermatol. 100: 225-228. (Pubitemid 23083160)
23. Leung, D. Y., H. C. Meissner, D. R. Fulton, D. L. Murray, B. L. Kotzin, and P. M. Schlievert. 1993. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342: 1385-1388. (Pubitemid 23361239)
24. Smoot, J. C., K. D. Barbian, J. J. Van Gompel, L. M. Smoot, M. S. Chaussee, G. L. Sylva, D. E. Sturdevant, S. M. Ricklefs, S. F. Porcella, L. D. Parkins, et al. 2002. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. USA 99: 4668-4673. (Pubitemid 34286042)
25. Llewelyn, M., and J. Cohen. 2002. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2: 156-162. (Pubitemid 34462450)
26. Rossi, R. J., G. Muralimohan, J. R. Maxwell, and A. T. Vella. 2004. Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation. Int. Immunol. 16: 1751-1760. (Pubitemid 40003863)
27. Müller-Alouf, H., J. E. Alouf, D. Gerlach, J. H. Ozegowski, C. Fitting, and J. M. Cavaillon. 1994. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect. Immun. 62: 4915-4921. (Pubitemid 24332796)
28. Lappin, E., and A. J. Ferguson. 2009. Gram-positive toxic shock syndromes. Lancet Infect. Dis. 9: 281-290.
29. Azuma, K., K. Koike, T. Kobayashi, T. Mochizuki, K. Mashiko, and Y. Yamamoto. 2004. Detection of circulating superantigens in an intensive care unit population. Int. J. Infect. Dis. 8: 292-298. (Pubitemid 39119853)
30. Danner, R. L., J. R. Elin, J. M. Hosseini, R. A. Wesley, J. M. Reilly, and J. E. Parillo. 1991. Endotoxemia in human septic shock. Chest 99: 169-175.
31. Brunialti, M. K., P. S. Martins, H. Barbosa de Carvalho, F. R. Machado, L. M. Barbosa, and R. Salomao. 2006. TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 25: 351-357.
32. Härter, L., L. Mica, R. Stocker, O. Trentz, and M. Keel. 2004. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22: 403-409. (Pubitemid 39472563)
33. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. (Pubitemid 38931765)
34. Murphy, K., P. Travers, and M. Walport. 2008. Signaling through immune system receptors. In Janeway's Immunobiology, 7th Ed. Garland Science, New York, p. 219-320.
35. Schlievert, P. M. 1982. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect. Immun. 36: 123-128. (Pubitemid 12156414)
36. Henne, E., W. H. Campbell, and E. Carlson. 1991. Toxic shock syndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice. Infect. Immun. 59: 2929-2933.
37. Wang, J. H., M. Doyle, B. J. Manning, S. Blankson, Q. D. Wu, C. Power, R. Cahill, and H. P. Redmond. 2003. Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J. Immunol. 170: 14-18. (Pubitemid 36026116)
38. Faulkner, L., A. Cooper, C. Fantino, D. M. Altmann, and S. Sriskandan. 2005. The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm. J. Immunol. 175: 6870-6877. (Pubitemid 41598932)
39. Chau, T. A., M. L. McCully, W. Brintnell, G. An, K. J. Kasper, E. D. Vinés, P. Kubes, S. M. Haeryfar, J. K. McCormick, E. Cairns, et al. 2009. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat. Med. 15: 641-648.